CMS Begins Contacting Hospitals About Drug Cost Survey Likely Tied to Future 340B Medicare Cuts

The Centers for Medicare & Medicaid Services is reaching out to hospital staff regarding its upcoming Medicare acquisition cost survey.
The Centers for Medicare & Medicaid Services (CMS) has begun reaching out to hospitals about an upcoming drug acquisition cost [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Nonprofit Hospitals’ Tax Exemptions, 340B Status Scrutinized in GOP-led U.S. House Hearing

U.S. House Ways & Means Chair Jason Smith (R-Mo.) said "there are a growing number of urban hospitals masquerading as rural facilities in order to get even more generous benefits under Medicare and the 340B drug program" during a Sept. 16 hearing.
Nonprofit hospitals’ financial practices and 340B eligibility came under sharp scrutiny during a recent Republican-led U.S. House subcommittee hearing on [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Industry Insights Logo

An Emerging Threat to Your 340B Program: DSH Percentage Reductions

SPONSORED CONTENT

The 340B program has been bombarded with threats over the past five years. 340B professionals have had their hands full defending the safety net program from contract pharmacy restrictions, state-level reporting, proposed legislative changes, the IRA, rebate models, and

Read More »

Drugmakers Ask Appeals Court to Reconsider Decision Allowing 340B Antitrust Lawsuit Against Insulin Drugmakers to Advance

Four drugmakers recently urged a federal appeals court to reconsider its August ruling that allows a 340B antitrust lawsuit to continue in district court.
Four major drugmakers recently urged a federal appeals court to reconsider its August ruling that allows a lawsuit—which alleges they [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Exelixis Tightens 340B Contract Pharmacy Restrictions, Adds Claims Data Requirements

Exelixis will implement new claims data and contract pharmacy restrictions on Oct. 1.
An oncology-focused biotech company recently announced it will soon set new limits on where it ships 340B-priced products and require [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Roundup: Updates in Tennessee, Arkansas, Colorado, Hawaii, Louisiana

Key briefs were filed recently in litigation over state 340B contract pharmacy laws in Tennessee, Arkansas, Colorado, Hawaii and Louisiana.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

RxParadigm

Q: Tell us some interesting details about your company’s history.

RxParadigm was built to stay ahead of the curve in healthcare’s most complex arenas. From our inception, we’ve focused

Read More »

340B Provider Advocates Slam CBO Report on 340B Growth and Budgetary Impact, Drug Industry Touts Findings

340B provider advocates have criticized findings in the CBO's recent report on the 340B program.
340B program advocates recently took aim at a new Republican-requested Congressional Budget Office (CBO) report on the 340B program, arguing [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

After 340B ACCESS Act’s Reintroduction, Critics Speak Out While Original Supporters Hold Back

The recently reintroduced 340B ACCESS Act has garnered criticism from a range of 340B provider groups, including one that supported last year's bill.
A controversial GOP-backed plan to overhaul the 340B program continued to draw pushback from provider advocates—as well as muted or [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Industry Insights Logo

FQHCs Face Unique Challenges—Strong Partnerships Can Make All the Difference

SPONSORED CONTENT

Federally Qualified Health Centers (FQHCs) play a critical role in delivering accessible and affordable healthcare to underserved communities. However, they are facing mounting challenges that threaten their ability to maintain operations and meet growing community needs. With limited infrastructure, evolving regulations, upcoming Medicaid cuts, drops in the insured

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live